We found that the antitumor function of NK cells in the peripheral blood of lung cancer patients was diminished compared to that in the healthy control donors, and the PD-1+ NK cell ratio in the lung cancer patients greatly exceeded that of the healthy individuals. This evidence concerns the gene PDCD1 and lung carcinoma.